Hologic, Inc. (HOLX) Tops Q2 EPS by 4c

Go back to Hologic, Inc. (HOLX) Tops Q2 EPS by 4c

Hologic (HOLX) PT, Estimates Raised at Jefferies Post Q2

May 1, 2014 9:46 AM EDT

Jefferies analyst Raj Denhoy lifted estimates and his price target on Buy-rated Hologic (NASDAQ: HOLX) to $26.00 (from $24.00) following solid Q2 results.

Denhoy commented, "HOLX put up a F2Q beat on strength in Tomo and... More

Hologic (HOLX) Buy Reiterated a Needham & Company Post Q2 on 'Encouraging' Return to Rev Growth

May 1, 2014 7:15 AM EDT

Needham & Company analyst Mike Matson reiterated a Buy rating and $26 price target on Hologic (NASDAQ: HOLX) following Q2 results which showed an 'encouraging' return to positive revenue growth.

Matson comments, "HOLX's F2Q14 results were well above consensus. Revenue upside was driven... More